Innovation in Ireland →
Head of global research and development at Life Technologies
Professor of Systems Biology, Columbia University
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Founder and CEO of Brooks Bell Inc.
Founder and CEO, Lighter Capital
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Managing General Partner at Pappas Ventures
March 11, 2015 ·
March 12, 2015 ·
April 7, 2015 ·
Matthew Scholz is the CEO of Immusoft, a (currently) Seattle based biotech startup that is commercializing technology to program the human immune system.
If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded... Read more »
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.